Published April 16, 1985 | Version v1
Patent Metadata-only

Method and composition for the detection of a precancerous or leukemic condition in mammals

Creators

Description

The invention is a method for detecting the presence of or a predisposition to cancer in mammalian individuals. A trace element, specifically tin, is administered to the individual in the form of a radioactive isotope or a compound containing a radioactive tracer. The tin-bearing compound thereafter accumulates in the various bodily organs and is excreted. Indicative of the presence of cancer or a predisposition is the lack of accumulation of the radioactive tin compound in the thymus and lymphatic system of the mammal. By comparison of the radioisotope concentration in the urine and blood, the early detection of a precancerous or leukemic condition can be made. The method is applicable to a wide variety of mammals, including human beings

Availability note (English)

U.S. Commissioner of Patents, Washington, D.C. 20231, USA, $.50.

Additional details

Publishing Information

Imprint Pagination
v p.
IPC:
Int. Cl. A61K 43/00; A61K 49/00.
IPC
Int. Cl. A61K 43/00; A61K 49/00.
Patent number
US patent document 4,511,551/A/

INIS

Country of Publication
United States
Country of Input or Organization
United States
INIS RN
17016507
Subject category
S60: APPLIED LIFE SCIENCES;
Resource subtype / Literary indicator
Non-conventional Literature
Descriptors DEI
BIOCHEMISTRY; MAMMALS; NEOPLASMS; NUCLEAR MEDICINE; PHYSIOLOGY; TIN ISOTOPES; TRACER TECHNIQUES
Descriptors DEC
ANIMALS; CHEMISTRY; DISEASES; ISOTOPE APPLICATIONS; MEDICINE; VERTEBRATES

Optional Information

Notes
PAT-APPL-442819.